Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
408 Results Found
President announces new tariffs, including for certain pharmaceuticals, set to begin Oct. 1
President Trump, late Sept. 25, announced that starting Oct. 1, the U.S. will impose a 100% tariff on any branded or patented pharmaceutical product, unless a company is building its pharmaceutical manufacturing plant in America.
AHA discusses reimbursement challenges, opportunities for innovation during Modern Healthcare event
Ashley Thompson, AHA senior vice president of public policy analysis and development, participated in a panel discussion during Modern Healthcare's Leadership Summit in Washington, D.C. on Sept. 25.
Commerce Department seeks comment on investigation of imported PPE, medical equipment for possible tariffs
The Department of Commerce Sept. 24 released a notice seeking public comment on an investigation it launched Sept. 2 on imports of personal protective equipment, medical consumables and medical equipment under Section 232 of the Trade Expansion Act of 1962.
FDA issues Class I recall for Olympus endoscope needles
The Food and Drug Administration has identified a Class I recall of certain Olympus ViziShot 2 FLEX Needles due to a possible patient safety issue caused by a potentially deformed a-traumatic tip.
AONL to host virtual Nurse Manager Institute
The AHA’s American Organization for Nursing Leadership will host its virtual Nurse Manager Institute on Oct. 30, Nov. 6 and Nov. 13.
AHA podcast: Elevating Hospitals Through Community Support
In this first episode of a four-part series with the Association for Healthcare Philanthropy, Alice Ayres, president and CEO of the AHP, discusses how philanthropy is no longer just an add-on but a strategic driver for hospitals and health systems.
FDA discloses warning letters for dozens of drug companies
The Food and Drug Administration recently disclosed dozens of warning letters sent to drug companies that accuse them of using misleading or deceptive advertising.
Trump directs HHS, FDA to require full safety warnings in drug ads
President Trump Sept. 10 signed a memorandum directing the Department of Health and Human Services and Food and Drug Administration to require drug companies to include full safety warnings on their consumer advertisements.
Indiana hospital CEO named to AHA Board of Trustees
The AHA Sept. 9 announced Eric Fish, M.D., president and CEO of Schneck Medical Center in Seymour, Ind., has been elected to fill a vacancy on its Board of Trustees effective immediately for a term that ends Dec. 31, 2026.
Administration modifies scope of reciprocal tariffs
The White House Sept. 5 issued an executive order modifying the scope of reciprocal tariffs announced in April to establish a framework of trade deals with international partners on certain goods such as critical minerals and pharmaceutical products.